Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer
Autor: | Marcin Magierowski, Marcin Surmiak, Grzegorz Ginter, Slawomir Kwiecien, Zbigniew Śliwowski, Tomasz Gromowski, Edyta Korbut, Magdalena Hubalewska-Mazgaj, Grzegorz Buszewicz, Dominik Bakalarz, Tomasz Brzozowski, Anna Chmura, Dagmara Wojcik, Katarzyna Magierowska |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
0301 basic medicine Arginine medicine.medical_treatment Ischemia Endogeny Pharmacology Nitric Oxide Biochemistry Nitric oxide Glibenclamide 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Enos Physiology (medical) Organometallic Compounds medicine Gastric mucosa Animals Humans Hydrogen Sulfide Saline Carbon Monoxide biology Gasotransmitters medicine.disease biology.organism_classification Rats Disease Models Animal Oxidative Stress 030104 developmental biology medicine.anatomical_structure chemistry Gastric Mucosa Reperfusion Injury Heme Oxygenase (Decyclizing) 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Free Radical Biology and Medicine. 145:198-208 |
ISSN: | 0891-5849 |
DOI: | 10.1016/j.freeradbiomed.2019.09.032 |
Popis: | Endogenous gaseous mediators, such as nitric oxide, hydrogen sulfide or carbon monoxide (CO) are known to exert anti-inflammatory and anti-oxidative activity due to modulation of various molecular pahtways. Therefore, we aimed to investigate if CO released from tricarbonyldichlororuthenium (II) dimer (CORM-2) prevents gastric mucosa against ischemia/reperfusion (I/R)-induced injury in male Wistar rats. Animals were pretreated i.g. With vehicle (DMSO and saline, 1:10), CORM-2 (1, 5 or 10 mg/kg) or zinc protoporphyrin IX (ZnPP, 10 mg/kg i.p.), the HMOXs inhibitor. In separate series, rats were pretreated with CORM-2 (5 mg/kg) applied in combination with glibenclamide (10 mg/kg i.g.), NG-nitro- l -arginine (L-NNA, 20 mg/kg i.p.), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 mg/kg i.p.) or indomethacin (5 mg/kg i.p.). I/R-injuries were induced by clamping celiac artery for 30 min (I) followed by removal of the clamp to obtain R for 3 h. The macroscopic and microscopic area of gastric damage, mucus production and protein expression for HMOX-1/Nrf-2 was determined by planimetry, histology and immunohistochemistry, respectively. Gastric mucosal HMOX-1, HMOX-2, COX-1, COX-2, Kir6.1, Sur2, sGC-α1, sGC-α2, iNOS and eNOS mRNA expression was assessed by real-time PCR. COHb in blood and gastric mucosal CO concentration was analyzed by gas chromatography. Serum content of TGF-β1, TGF-β2, TGF-β3, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12, TNF-α, IFN-γ, GM-CSF was evaluated using Luminex platform. PGE2 concentration and 8-hydroxyguanozine (8-OHG) concentration in gastric mucosa was determined by ELISA. Exposure to I/R induced extensive hemorrhagic erosions in gastric mucosa pretreated with vehicle as compared with intact rats and the area of this gastric damage was reduced by pretreatment with CORM-2 (5 mg/kg i.g.). This effect of CO donor was accompanied by the increased PGE2 content and a significant decrease in 8-OHG and expression of pro- and anti-inflammatory markers mRNA and proteins. Concurrent treatment of CORM-2 with glibenclamide, L-NNA, ODQ but not with indomethacin significantly increased the area of I/R-induced injury and significantly decreased GBF as compared with the group treated with CORM-2 alone. We conclude that CO releasing CORM-2 prevents gastric mucosal oxidative damage induced by I/R improving GBF, decreasing DNA oxidation and inflammatory response on systemic level. This CO-gastroprotection is mediated by the activity of sGC, NOS and K-ATP channels. CO delivered from its donor maintained physiological gastric mucosal PGE2 concentration but the involvement of endogenous COX in beneficial activity of this gaseous mediator at least in this model is questionable. |
Databáze: | OpenAIRE |
Externí odkaz: |